Hi Ratfink,
The CHF result was listed as a corporate update. So it could possibly be about the trials.
In my humble opinion it could well be COVID
a) overwhelming efficacy and they are looking at options
b) futility and they are also looking at options
To me it makes more sense if it’s trial results that it would be COVID, otherwise just release CLBP as they did CHF.
The other possible options are FDA letter or partnership deal.
Everyone is speculating, as after all it is a speculative stock, however we don’t have to wait long to find out, and soon, hopefully it will no longer be a speculative stock!
GLTAH
Ann: Trading halt, page-432
-
- There are more pages in this discussion • 365 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |